Inducing Remission in Type 1 Diabetes With Alefacept (T1DAL)

This study is ongoing, but not recruiting participants.

Sponsor:

Collaborator:

Immune Tolerance Network (ITN)

Information provided by (Responsible Party):

National Institute of Allergy and Infectious Diseases (NIAID)

ClinicalTrials.gov Identifier:

NCT00965458

First received: August 22, 2009

Last updated: March 20, 2013

Last verified: March 2013

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	August 2014
Estimated Primary Completion Date:	March 2013 (Final data collection date for primary outcome measure)